Early Signal Foundation

Early Signal Foundation is a non-profit research organization focused on the development of digital health technologies and biomarkers for rare and neurodevelopmental disorders. The foundation utilizes wearable sensors and mobile applications to collect high-frequency, real-world data from patients, which is then analyzed using proprietary algorithms to identify early indicators of disease progression or therapeutic efficacy. By providing a robust data integration platform, Early Signal supports clinical trials and personalized medicine initiatives for conditions such as Rett Syndrome and Fragile X. Their mission is to accelerate the development of treatments by improving the precision and sensitivity of clinical outcome measures. The organization works closely with patient advocacy groups to ensure that digital endpoints are meaningful to the patient community.